CNTB — Connect Biopharma Holdings Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
- $88.47m
- $88.88m
Annual cashflow statement for Connect Biopharma Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -93.9 | -169 | -779 | -1,305 | -795 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 30.3 | 61.2 | 613 | 735 | 59.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.07 | 16.4 | -2.85 | 20.8 | 49 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -69 | -90.3 | -167 | -545 | -680 |
| Capital Expenditures | -1.19 | -1.07 | -15.3 | -25.2 | -29.3 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 59.3 | -2.27 | 18.2 | -8.78 | -542 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 58.1 | -3.34 | 2.93 | -34 | -571 |
| Financing Cash Flow Items | -9.86 | 0 | -3.95 | -111 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 369 | -0.396 | 919 | 1,316 | -0.625 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 361 | -92.6 | 701 | 697 | -1,157 |